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ABSTRACT  27 
Some bacterial pathogens can manipulate the angiogenic response, suppressing or inducing it for their 28 
own ends. In humans, B. henselae is associated with cat-scratch disease and vasculoproliferative 29 
disorders such as bacillary angiomatosis and bacillary peliosis. Although endothelial cells (ECs) 30 
support the pathogenesis of Bartonella, the mechanisms by which Bartonella induces EC activation 31 
are not completely clear, as well as the possible contribution of other cells recruited at the site of 32 
infection.   Mesenchymal stromal cells (MSCs) are endowed with angiogenic potential and play a 33 
dual role in infections exerting antimicrobial properties but also acting as a shelter for pathogens.  34 
Here we delved into the role of MSCs as reservoir of Bartonella and modulator of EC functions. B. 35 
henselae readily infected MSCs and survived in perinuclear bound vacuoles for up to 8 days.  36 
Infection enhanced MSC proliferation and the expression of EGFR, TLR2 and NOD1, proteins that 37 
are involved in bacterial internalization and cytokine production. Secretome analysis revealed that 38 
infected MSCs secreted higher levels of the proangiogenic factors VEGF, FGF-7, MMP-9, PIGF, 39 
serpin E1, TSP-1, uPA, IL-6, PDGF-D, CCL5 and CXCL8. Supernatants from B. henselae-infected 40 
MSCs increased the susceptibility of ECs to B. henselae infection and enhanced EC proliferation, 41 
invasion and reorganization in tube-like structures.  42 
Altogether, these results candidate MSCs as a still underestimated niche for B. henselae persistent 43 
infection and reveal a MSC-EC crosstalk that may contribute to exacerbate bacterial-induced 44 
angiogenesis and granuloma formation. 45 
 46 
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Endemic among domestic cats, B. henselae is a fastidious gram-negative bacterium that, in humans, 54 
can cause subclinical intraerythrocytic bacteremia, mainly transmitted by cat fleas. In 55 
immunocompetent individuals, B. henselae infection can also lead to cat-scratch disease (CSD), 56 
characterized by lymphadenopathy with suppurative granulomas. Atypical clinical presentations of 57 
CSD, ranging from prolonged fever of unknown origin to hepatosplenic, ocular and neurological 58 
manifestations, have also been reported (1).  59 
 Individuals unable to mount an immune response against B. henselae tend to develop a tumor-60 
like vascular proliferative response in the skin and/or internal organs, which can lead to bacillary 61 
angiomatosis (BA) or bacillary peliosis (BP) (2). After infection, B. henselae survives, stimulates the 62 
migration and the production of pro-angiogenic factors by human endothelial cells (ECs) (2–5). In 63 
addition, other cells types, such as monocytes/macrophages (6), recruited to the vasoproliferative 64 
lesions, stimulate EC proliferation in a paracrine manner through the production of VEGF and 65 
CXCL8 (7). Mononuclear phagocytes, CD34+ progenitor cells and ECs can also function as a 66 
reservoir from which B. henselae periodically enters the bloodstream and disseminates within the 67 
host (8). Despite the clinical implications of protracted Bartonella infections, the underlying 68 
mechanism of intracellular B. henselae persistence is poorly understood, and the existence of different 69 
reservoirs still remains to be determined. 70 
 Mesenchymal stem cells (MSCs) are multipotent adult stem cells present in various tissues, 71 
including the bone marrow and the adipose tissue, which have recently received much attention due 72 
to their regenerative potential and immunomodulatory properties (9). MSCs actively participate in 73 
angiogenesis through several mechanisms, including paracrine cytokines and exosomes and cell 74 
contact interactions with endothelial cells. (10, 11). A diverse and multitasking role of MSCs during 75 
bacterial infection has recently emerged (12, 13). MSCs can sense pathogens and mount an 76 
appropriate cytokine/chemokine response through the activation of Toll-like receptors (TLRs), NOD-77 
like receptors (NLRs) and the scavenger receptors MARCO and SR-B1 (12). Moreover, MSCs 78 
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express EGFR, a (member of the ErbB receptor tyrosine kinase family), shown to enhance their 79 
proliferation and the release of angiogenic factors (14).  However, despite the emerging role of MSCs 80 
in infectious diseases, the mechanisms regulating the interplay between MSCs and bacteria are yet to 81 
be defined. Recent evidence suggests that MSCs can have a double edge sword effect by playing a 82 
role in clearing infection but also promoting persistent bacterial infection. MSCs exert antimicrobial 83 
effects by secreting antimicrobial peptides and expressing indoleamine2,3-dioxygenase (IDO) and 84 
MSC administration reduce pathogen burden in animal models of antimicrobial sepsis (12). However, 85 
MSCs  can also serve as a niche where M. tuberculosis can survive and persist during antimicrobial 86 
therapy. Indeed, viable M. tuberculosis was recovered from MSCs infiltrating TB granulomas in 87 
humans and in a tuberculosis mouse model (15, 16). It is likely that other chronic bacterial pathogens 88 
may exploit MSCs to favor their survival in the host.and  we hypothesized that B.henselae infects 89 
MSCs and that infected-MSCs contribute to the angiogenesis via interaction with endothelial cells 90 
that are one of Bartonella preferential target. 91 
Here we show that B. henselae can invade and survive within human MSCs and demonstrate that 92 
TLR2, NOD1 and EGFR are implicated in bacterial recognition and cytokine production. Moreover, 93 
we provides evidence for a MSCs-ECs cross-talk involved in bacteria intracellular survival and 94 
activation of a pro-angiogenic program.  95 
   96 
 97 
RESULTS 98 
 B. henselae invades and persists in MSCs. To characterize the interaction of MSCs with B. 99 
henselae, adipose-derived MSCs were infected with MOI of 100:1 for 1, 2, 3, 4 and 8 days and then 100 
treated with gentamicin to kill all residual extracellular bacteria. Subsequently, the number of viable 101 
intracellular bacteria was measured by colony-forming unit (CFU) assay. The number of B. henselae 102 
invading MSCs increased progressively over a 3-day period and the number of CFUs in MSCs 103 
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remained unchanged up to 8 days (P < 0.05) (Fig. 1a). At day 8 post-infection (pi), the vast majority 104 
of MSCs contained B. henselae, as demonstrated by the strong cytoplasmic reactivity of an anti-B. 105 
henselae monoclonal antibody (anti-BH) (Fig. 1b, upper panel). The presence of internalized bacteria 106 
was confirmed by immunofluorescence (Fig. 1B, lower panel). To assess B. henselae 107 
intracellular survival after the initial infection and gentamicin treatment, MSCs were cultured in 108 
medium without gentamicin for four additional days. The number of viable intracellular bacteria 109 
recovered, which remained stable during the first 96 h, was significantly lower at day 8 compared to 110 
day 4 (Fig. 1c). The ability of B. henselae to invade MSCs was further assessed by comparing its 111 
infection efficiency in MSCs vs HUVECs, a known target of B. henselae infection. The number of 112 
intracellular bacteria recovered after 24 h of infection from MSCs was significantly higher than that 113 
recovered from HUVECs (Fig. 1d). 114 
 Next, we followed MSC infection by fluorescence microscopy. At day 1 pi, B. henselae—115 
stained with DAPI (Cyan)—remained mainly anchored to the MSC membrane, with only a few 116 
bacteria present in the cytoplasm (Fig. 2a, upper right panel, arrowhead). From day 2 pi onward, the 117 
number of internalized bacteria increased, and most of B. henselae were enclosed in perinuclear 118 
vesicles   (Fig. 2a, lower left and central panel, thin arrows). After 8 days pi, aggregates of bacteria 119 
colocalized with F-actin in globular structures called invasomes, first described in Bartonella-infected 120 
ECs (Fig. 2a, lower right panel, large arrow; and Fig. 2b) as attested by 3D immunofluorescence 121 
analysis.  122 
 Altogether, these findings indicate that B. henselae is internalized by MSCs—even more 123 
efficiently than HUVECs—where it can persist for a prolonged time. 124 
 B. henselae infection enhances MSC proliferation. We next asked whether B. henselae 125 
infection would affect MSC survival. B. henselae infection did not induce cell death in MSCs as 126 
demonstrated by similar amounts of Annexin V positive cells found in uninfected vs infected MSCs 127 
(Fig. 3a). This finding was further supported by the unaltered Bcl-2 (antiapoptotic) /Bax (apoptotic) 128 
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expression ratio observed in these cells (Fig. 3b). We then assessed the effect of infection on the 129 
proliferation rate of MSCs. Infected-MSCs grew significantly faster compared to their uninfected 130 
counterparts. Conversely, heat-inactivated B. henselae (HK B.henselae) failed to enhance MSC 131 
proliferation (Fig. 3c).  132 
 Role of TLR2, EGFR and NOD1 in MSC infection with B. henselae. TLRs and NODs 133 
play a key role in bacterial detection and their cooperation become relevant in the context of 134 
infections. Interaction between cell surface TLR2 and intracellular surveillance NOD1/2 are of 135 
relevance in the recognition of pathogens and in the induction of  the inflammatory response (17). 136 
However a number of cell surface receptors, such EGFR, that signal through pathways not related to 137 
TLRs and NODs, are also used by pathogens and an interaction between TLRs and EGFR has been 138 
demonstrated (18, 19). 139 
We therefore assessed the expression of these receptors in response to B. henselae infection. 140 
Interestingly, B. henselae infection led to a more than 6-fold increase in TLR2 expression at both 141 
mRNA and protein levels, while TLR4 expression remained basically unchanged (Fig. 4a and 4b). 142 
Furthermore, RT-PCR analysis showed a significant upregulation of NOD1 mRNA at day 2 and 4 pi 143 
(Fig. 4a). NOD2 gene expression was not detected in uninfected or infected MSCs. Lastly, B. 144 
henselae infection significantly increased EGFR mRNA and phosphorylation levels (Fig. 4a and 4c, 145 
respectively). Specifically, we detected increased phosphorylation as early as 30 min pi, which 146 
remained above basal levels up to 120 min pi (Figure 4c).  147 
 The involvement of these receptors was evaluated in the production of CXCL8,  a cytokine 148 
shown to be triggered by Bartonella in different cell types (20),  Bartonella infection of MSCs 149 
enhanced their ability to produce CXCL8, which was neutralized by incubation with an anti-TLR2 150 
neutralizing antibody (Fig. 4d, upper panel). Similarly, treatment with the EGFR inhibitor gefitinib 151 
or with the selective RIP2K inhibitor GSK583 significantly reduced the release of CXCL8 in B. 152 
henselae-infected MSCs (Fig. 4d, lower panel), suggesting that the EGFR/NOD pathway may play a 153 
role in CXCL8 transcriptional regulation. Finally, to address the role of bacterium-activated EGFR 154 
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in Bartonella entry, we treated MSCs with the EGFR inhibitor gefitinib and a neutralizing anti-EGFR 155 
antibody, detecting a reduced bacterial internalization by about 70% and 50%, respectively, compared 156 
to untreated cells (Fig. 4e). 157 
 B. henselae-infected MSCs promote angiogenesis and infection of endothelial cells. Since 158 
MSCs regulate vascular remodeling and angiogenesis (21), we assessed the pro-angiogenic activity 159 
of conditioned medium (CM) from B. henselae-infected MSCs. To this end, CM from uninfected or 160 
B. henselae-infected MSC cultures were tested in a scratch wound healing assay using HUVECs. CM 161 
from B. henselae-infected MSCs (CM-MSC B. henselae), induced a more rapid repair of HUVECs 162 
monolayer (Fig. 5a). In addition, the CM-MSC B. henselae was 9 fold more powerful then CM of 163 
uninfected MCS (CM-MSC CTRL) on aspheroid-based sprouting assay, which faithfully recapitulate 164 
the proliferation, invasion and reorganization in tube-like structure of ECs  (Fig. 5b). In keeping with 165 
the pro-angiogenic activity of MSCs, the CM-MSC CTRL induced the formation of radial sprouts, 166 
similarly to what induced by spheroids stimulation with 30 ng/mL of VEGF-A (Fig. 5b, right panel).  167 
Importantly, CM-MSC B. henselae but not that from uninfected cells (CM-MSC CTRL) accelerated 168 
the morphogenesis of HUVECs when seeded on Cultrex Extracellular Matrix, as judged by the 169 
number of closed structures formed at 18 h pi (Fig. 5c).  170 
 Even though ECs and MSCs can crosstalk through soluble mediators (22), there is no data on 171 
the effects of MSC on the susceptibility of ECs to bacterial infection. We thus assessed the extent of 172 
Bartonella internalization, at day 1 pi, in HUVECs pretreated with CM from uninfected MSCs (CM-173 
MSC CTRL) or B. henselae-infected MSCs (CM-MSC B. henselae).  While there were no differences 174 
in the yield of bacteria between control HUVECs (Ctrl) and HUVECs pretreated with CM-MSC 175 
CTRL, a significantly higher number of bacteria was detected in HUVECs pretreated with CM-MSC 176 
B. henselae (Fig. 5d). After 1 day of culture we did not observe a significant increase in the  177 
proliferation of infected HUVECs pre-treated with CM-MSC B. henselae over that pre-treated with 178 
CM-MSC CTRL, or directly infected. The number of cells harvested/number of cells seeded (mean 179 
± SEM) obtained were 1.23±0.2 (unconditioned medium), 1.063±0.06 (B. henselae infected), 180 
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1.125±0.1 (CM-MSC CTRL) and 1.25±0.05 (CM-MSC B. henselae).  In accord with our observation 181 
endothelial cell proliferation during B. henselae infection has been shown after 3 or 4 days of 182 
incubation (7, 23) . Our results indicate that the treatment with CM-MSC B. henselae makes HUVECs 183 
more infectable and the increase in intracellular CFU does not depend on HUVEC proliferation. 184 
 Angiogenic expression profile of B. henselae-infected MSCs. Finally, we assessed the 185 
impact of B. henselae infection on the ability of MSCs to modulate the expression of pro-186 
inflammatory and pro-angiogenetic molecules. For this purpose, we probed an antibody angiogenesis 187 
array with CM from uninfected and 4-day-infected MSCs. Among the 55 proteins of the assay, 27 188 
were detected in CM of both uninfected and infected MSCs. Densitometric analysis showed the 189 
upregulation of FGF-7, CXCL8, MMP-9, PIGF, Serpin E1, TSP-1, uPA and VEGF, in B. henselae-190 
infected MSCs CM compared to those from uninfected MSCs (Fig. 6a and 6b). Intriguingly, activin 191 
A was the only growth factor downregulated in B. henselae-infected MSCs (Fig. 6a and 6b). Of note, 192 
the elevated expression of MCP-1, PTX3 and TIMP-1 was not modulated by infection (Fig. 6a, and 193 
6b). The quantification by ELISA of the increased production of CXCL8 and VEGF in the 194 
supernatants of MSCs infected for 1, 4 and 7 days was in good agreement with the array data (Fig. 195 
6c). Finally, other molecular factors known for their angiogenic activity, but not included in our array, 196 
such as IL-6, CCL5 and PDGF-D, were also induced following B. henselae infection (Fig. 6c).   197 
DISCUSSION 198 
  Bartonella spp exploits several mechanisms to hide inside erythrocytes and ECs to evade 199 
immune responses and persist in both animal reservoir and human host. Numerous evidence indicate 200 
that the blood-stage phase is preceded by the infection of cellular niches that periodically release 201 
bacteria able to invade erythrocytes. ECs were the first cell types considered a primary niche as they 202 
support Bartonella replication and reside in proximity to the bloodstream (2, 24). However, later 203 
studies identified additional Bartonella persistence sites including hematopoietic progenitor cells and 204 
dendritic cells (8, 25). 205 
Here we show that once inside, B. henselae resides in MSCs without proliferating for several 206 
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days. During this time, Bartonella localizes in numerous perinuclear membrane bound vacuoles, as 207 
previously shown in HUVECs and MonoMac cells (26, 27), or at late time points of infection, as 208 
aggregated bacteria enclosed into F actin-rich cell membrane protrusions identified as  invasome 209 
structures (28).  210 
MSCs sense microorganisms trough the expression of various PRR including Toll-like 211 
receptors (TLRs) and Nod-like receptors (NLRs). The engagement of such receptors modulate MSC 212 
functions and their abilities to secrete cytokines (29). Our studies revealed that TLR2, NOD1 and 213 
EGFR are involved in the recognition and responses to Bartonella by MSCs.  Upon infection with B. 214 
henselae, MSCs secret large amounts of CXCL8, which is curbed by incubation with an anti-TLR2 215 
antibody. A central role of TLR2 signaling during Bartonella infection is consistent with previous 216 
findings indicating that B. henselae, despite being Gram-negative, preferentially activates TLR2 (25). 217 
In infected cells, NOD1 and NOD2 recognize bacterial peptidoglycan derivatives released into the 218 
cytosol and, upon ligand association with the adaptor protein receptor-interacting-serine/threonine-219 
protein kinase 2 (RIPK2 or RIP2), trigger proinflammatory signaling (30). In our experimental 220 
system, inhibition of the RIP2 with the highly RIPK2-specific compound GSK583(31) decreased 221 
CXCL8 release, indicating that NOD1 activation and signaling through RIP2 during MSC infection 222 
is, in part, responsible for inducing the inflammatory response to B. henselae infection. Consistent 223 
with our results, NOD1 mediates CXCL8 induction after recognition of Helicobacter pylori, 224 
Escherichia coli (32, 33) and Chlamydia pneumoniae (34). Importantly, gefitinib, an inhibitor of 225 
EGFR tyrosine kinase domain, used to treat various forms of cancer, can hamper B. henselae-226 
mediated induction of CXCL8, suggesting a role of EGFR in this pathway. Gefitinib also exerts an 227 
off-target inhibitory activity on the expression of RIP2 (35), thus the  inhibition of CXCL8 secretion 228 
may be due to blockage of NOD/RIP2 signaling alongside that of EGFR. In support to this hypothesis, 229 
EGFR/NOD cooperation has been recently involved in cytokine production in dengue virus infected 230 
monocytes (36). Moreover, a growing body of literature highlights the importance of EGFR/ErbB in 231 
several bacterial and viral inflammatory responses (18, 37) and in pathogenic angiogenesis (38). In 232 
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addition to stimulation of EGFR tyrosine phosphorylation, Bartonella enhanced EGFR mRNA 233 
expression suggesting that this upregulation could serve as a positive feedback system. A functional 234 
role of EGFR signaling in the immune response against B. henselae is further supported by the 235 
observation that treatment of MSCs with the kinase inhibitor gefitinib or an anti-EGFR antibody 236 
significantly decreases Bartonella internalization. In this regard, EGFR has been recently shown to 237 
act as a cofactor in mediating pathogen internalization in host cells (e.g., HBV, HCV, Chlamydia and 238 
Candida) (18). Our finding indicates an important role of EGFR activation in Bartonella invasion; 239 
however, as these EGFR inhibitors do not completely abrogate Bartonella uptake by MSCs, it is 240 
likely that other receptors, other than EGFR, may play a role in Bartonella infection. Moreover, it 241 
remains to be investigated whether EGFR activation is due to the direct interaction of Bartonella with 242 
the EGFR extracellular domain or by its transactivation by EGFR ligands (i.e., EGF, HBEGF, TGFα, 243 
BTC, AREG, EREG and EPGN) as shown for H. pylori and Neisseria spp. (39, 40). EGFR signaling 244 
pathways exert an antiapoptotic activity in Pseudomonas- and Helicobacter- infected cells (41, 42) 245 
suggesting that EGFR activation by Bartonella promotes the survival and proliferation of infected 246 
MSCs.  247 
These effects may also be explained at least in part by the robust release of cytokine/growth 248 
factors caused by Bartonella infection.  In addition to CXCL8, angiogenic factors upregulated in 249 
infected MSCs include FGF-7, MMP-9, PIGF, serpin E1, TSP-1, uPA, IL-6, CCL5 and VEGF, 250 
leading to the induction of a pro-angiogenic phenotype in ECs as well as an increased susceptibility 251 
of ECs to infection.. Data reporting a role of MSCs in facilitating the infection of other cell types are 252 
sparse and concern mainly phagocytic cells. MSCs was shown to enhance bacterial uptake and 253 
clearance by PMNs (43), and to mediate the reactivation of HIV in monocytic cells (44). A secretome 254 
highly rich in inflammatory angiogenic cytokines and matrix remodeling factors was previously 255 
described in B. henselae infected myeloid angiogenic cells (MACs). Similarly to our observation in 256 
MSCs conditioned  medium from MACs increased angiogenic sprouting (45). In the past, infected 257 
ECs have been shown to upregulate the expression of VEGF and CXCL-8 that  directly lead to host 258 
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cell proliferation and potentiate angiogenesis (23, 46); in parallel, Bartonella triggers the release of 259 
proinflammatory chemokines which recruit monocytes/macrophages in the vasoproliferative lesions 260 
and the production of angiogenic factors by phagocytic cells upon infection plays a central role in 261 
mediating angiogenesis-(7, 20, 45). . Since at sites of infection/inflammation, MSCs localize in 262 
contact with ECs (22, 47), we propose that infected MSCs may support this angiogenic loop.  263 
A role for MSCs can be envisioned in different scenarios of Bartonella infections. For 264 
instance, MSCs are recruited in tuberculosis around the lymph node granulomas to establish a 265 
persistent infection and likely to suppress T cell response (48). Moreover, MSCs are found in oral 266 
pyogenic granuloma tissues (49). Granulomatous lymphadenitis is the pathological hallmark of cat 267 
scratch disease whereby MSCs could also be hired in Bartonella granuloma to contribute to the 268 
immune pathogenesis. MSCs reside in the bone marrow (BM) interacting with other cellular 269 
components. We have previously shown the co-localization DCs and MSCs in human BM (50). The 270 
role of MSC-EC crosstalk has been characterized in the maintenance of the hematopoietic stem cell 271 
niche and in infection-induced emergency myelopoiesis (51, 52). Interestingly MSCs were shown to 272 
regulate proliferation and erythroid differentiation of CD34+ stem cells (53). As B. henselae can infect 273 
CD34+ BM progenitor cells, BM has been proposed as one of the potential niches. In this regard, 274 
multifocal BM involvement was shown in CSD (54, 55) and a contribution of B. henselae to 275 
ineffective erythropoiesis was suggested (56). Bartonella-infected MSCs, releasing soluble 276 
molecules, can recruit and activate ECs which in turn collaborate with MSCs in the fine regulation of 277 
the hematopoietic stem cell niche.  278 
In conclusion, this study provides novel insights into the role of MSCs in serving as a reservoir 279 
during B. henselae infection and identifies TLR2, NOD1 and EGFR as the receptors involved in the 280 
recognition of B. henselae. Infection of MSCs triggers a potent proangiogenic program, which 281 
activates and enhances EC susceptibility to bacterial infection. A better understanding of the 282 
involvement of MSCs in Bartonella-induced angiogenesis may allow the development of targeted 283 
therapeutic strategies for the treatment of vascular proliferative disorders. 284 
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MATERIALS AND METHODS 285 
  286 
 Cell culture. Human MSCs were isolated from adipose tissues as previously described (50). 287 
Human adipose tissues were collected by lipoaspiration from healthy donors after written consent and 288 
in compliance with the Declaration of Helsinki and the local Ethic Committee (Comitato Etico 289 
Interaziendale A.O.U. Città della Salute e della Scienza di Torino - A.O. Ordine Mauriziano - ASL 290 
TO1, No. 0009806). Subsequently, MSCs were analyzed by flow cytometry to verify their phenotype 291 
was positive for CD73, CD90 and CD105 and negative for CD11b, CD34 and CD45. 292 
 HUVECs were isolated from umbilical cords of healthy informed volunteers in compliance 293 
with the Declaration of Helsinki. HUVECs were used at early (I-IV) passages and grown on culture 294 
plates coated with porcine gelatin in M199 medium (Gibco Life Technologies, ThermoFisher 295 
Scientific Group) supplemented with 20% heat-inactivated fetal calf serum (FCS, Gibco Life 296 
Technologies), endothelial cell growth factor (ECGF) (10 µg/mL), and porcine heparin (100 µg/mL) 297 
(Sigma Aldrich) (100 μg/mL) or in complete EBM2 medium (Lonza Group Ltd  Basel, Switzerland). 298 
 Bacterial cultures. B. henselae Houston I strain (ATCC 49882; Manassas, VA, USA) was 299 
grown on 5% sheep blood Columbia agar plates (BioMerieux, Lyon, France) under anaerobic 300 
conditions (i.e., candle jar) at 37°C for 10 days. Bacteria were harvested under a laminar-flow hood 301 
by gently scraping colonies off the agar surface. They were then suspended in MICROBANKTM 302 
cryopreservative solution and stored at -80°C in 1-mL aliquots. For biological assays, frozen bacteria 303 
were incubated in Schneider’s Insect Medium (Sigma-Aldrich) supplemented with 10% FBS, as 304 
described by Riess et al (57), at 37°C and 5% CO2 for 6 days. Spectrophotometry was performed to 305 
evaluate bacterial growth [optical density (OD600) 0.6, corresponding to 1x108 bacteria/mL] and 306 
confirmed by plating serial dilutions on 5% sheep blood Columbia agar plates. Bacteria, washed 3 307 
times with 1X PBS, were then added to cell cultures. Where indicated, B. henselae were killed by 308 
heating thawed bacteria at 56°C for 30 min.  309 
Preparation of conditioned medium. MSCs, cultured into 12-well plates at a density of 310 
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0.5 × 105 cells/well in RPMI 10% FBS without antibiotics, were left untreated or infected for 96 h  311 
with B. henselae. Cells were then extensively washed to remove extracellular bacteria, and fresh 312 
RPMI was replaced for 72 h. Conditioned medium was collected, centrifuged at 4000 rpmi for 10 313 
min and then filtered, aliquoted, and stored at -20°C. 314 
 Infection assay. B. henselae invasion of MSCs was assessed by GPA. Briefly, 12,500 315 
cells/cm2 MSCs were seeded for 24 h in RPMI supplemented with 10% FCS. To compare MSCs with 316 
HUVECs, infection was carried out with 60,000 cells per well seeded in DMEM 10% FCS or 317 
complete EBM2 medium (Lonza Group Ltd), respectively. The next day, cells were washed twice 318 
and cultured in RPMI supplemented with 10% FCS without antibiotics. B. henselae (MOI 100) was 319 
added to the cells, immediately centrifuged at 1200 g for 5 min to allow the association of bacteria 320 
with the cellular surface, and incubated for 1, 2, 3, 4 and 8 days. At the end of infection period, 321 
gentamicin sulfate (Sigma-Aldrich) (100 μg/mL) was added to the medium for 2 h to kill all 322 
extracellular bacteria—this assay was performed in triplicate, and control wells were left uninfected. 323 
Cells were then washed extensively and lysed by the addition of 200 μL of distilled water for 5 min 324 
and sonicated for 1.30 min. Lysates were serially diluted, plated on Columbia blood agar, and CFUs 325 
were counted after 1 week of incubation. To determine intracellular survival after 96 h of infection, 326 
extracellular bacteria were killed by gentamicin treatment for 2 h. Cells were further incubated in 327 
normal medium for the remaining time of the indicated infection period. When indicated, cells were 328 
pretreated for 6 h with the specific inhibitors gefitinib (10 μM) and GSK583 (1 μM) (both from 329 
MedChemExpress NJ, USA) or with a specific antibody against EGFR (mouse IgG1, clone LA1) or 330 
its corresponding isotype control antibody (both from EMD Millipore Corporation CA, USA) at 10 331 
μg/ml.. GPA was performed as described above after 1 or 2 days. In some experiments, HUVECs 332 
were cultured in the presence of CM from untreated and infected MSCs. Briefly cells seeded at 60,000 333 
cells per well were pretreated overnight with the indicated CM and then infected with B. henselae 334 
(MOI 100) for 24 h. Cells were harvested and counted directly with an hemacytometer. Proliferation 335 
is reported as an index calculated as number of cells harvested/number of cells seeded. In parallel a 336 
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GPA assay was performed. 337 
 Staining procedures. MSCs (1 × 104) were seeded on glass coverslips and infected with B. 338 
henselae at a MOI of 100. For immunohistochemical staining, cells were fixed in methanol, saturated 339 
with 0.1% BSA in PBS and incubated for 1h with an anti-B henselae mAb (anti-BH, dilution 1:50, 340 
mouse IgG2b/clone H2A10,  Abcam , Cambridge, United Kingdom).The H2A10 clone reacts with a 341 
43-kDa epitope present only in B. henselae strains and not in other Bartonella species (58). After 342 
washing an anti-mouse biotinylated Ab was added for 30 min. and the slides were then stained with 343 
horseradish peroxidase streptavidin (HRP Streptavidin) or with the chromogen DAB (3, 3’-344 
diaminobenzidine) (ThermoFisher Scientific). For immunofluorescence analysis, the slides were 345 
incubated with anti-BH mAb, followed by goat anti-mouse Alexa Fluor® 594 (dilution 1:500, 346 
A21023, ThermoFisher Scientific). Nuclei were counterstained with DAPI (4',6-diamidin-2-347 
fenilindolo) (ThermoFisher Scientific). To follow bacterial infection, MSCs were seeded at 0.25 ×104 348 
on glass coverslips, infected with B. henselae (MOI 100) and incubated for 1, 2, 3, 4 and 8 days. At 349 
the end of infection period, cells were fixed with 4% paraformaldehyde (PFA) for 10’, washed with 350 
PBS and permeabilized in PBS with 0.25% saponin. Samples were then saturated with blocking 351 
solution (PBS with 5% normal goat serum, and 2% BSA) for 1h at RT. After washes in PBS, samples 352 
were incubated with the wheat germ agglutinin-Alexa Fluor 594 or 488 conjugate, Alexa Fluor® 594 353 
phalloidin (A12381) (1 h) and with DAPI (5 min) (all from ThermoFisher Scientific CA, USA) to 354 
stain cell membranes, actin and nuclei/bacteria respectively.  Cells were analyzed under a Zeiss 355 
Observer.Z1 epifluorescence microscope equipped with a Plan-Apochromat 100×/1.4 NA oil 356 
objective and ApoTome2 imaging system for optical sectioning. Z-stack images were elaborated 357 
through AxioVision 3D and Extended Focus modules. 358 
 Immunoblotting. Total cell lysates from cellsuntreated or treated for 30, 60 and 120 min. 359 
with B. henselae (MOI 100) or with 50 ng/ml EGF (R&D System, MN, USA) for 15 min, were 360 
prepared in cold lysis buffer (1% Triton X-100, 1% NP-40 in PBS, pH 7.4) containing a cocktail of 361 
protease and phosphatase inhibitors (Sigma-Aldrich). Samples (10-20 μg) were analyzed by 10% 362 
15 
 
SDS-PAGE under denaturing conditions, followed by Western blotting, using the antibodies against 363 
EGFR (clone A10, sc-373746), pY1068-EGFR (sc-377547) and secondary antibodies HRP-conjugated 364 
(all from Santa Cruz Biotechnology, Inc.,Texas, USA). the indicated antibodies . Chemiluminescent 365 
signal (Clarity Western ECL Substrate, Bio-Rad) was acquired by ChemiDocTM Imaging System 366 
(BioRad). 367 
 Real-time PCR. Total MSC RNA isolated with the Qiagen RNeasy mini kit was treated with 368 
DNase I (Qiagen, Hilden, Germany) and retrotranscribed into cDNA by iScript cDNA Synthesis Kit 369 
(Bio-Rad Laboratories Inc., Hercules, CA, USA). Gene specific primers were:  370 
TLR-2 (sense, 5'- CTCATTGTGCCCATTGCTCTT -3'; antisense, 5'- 371 
TCCAGTGCTTCAACCCACAAC -3'), TLR-4 (sense, 5'- GGCCATTGCTGCCAACAT -3'; 372 
antisense, 5'- CAACAATCACCTTTCGGCTTTT -3'), Bax (sense, 5'- 373 
AGAGGATGATTGCCGCCGT -3'; antisense, 5'- CAACCACCCTGGTCTTGGATC -3'), Bcl-2 374 
(sense, 5'- TGCA.CCTGACGCCCTTCAC -3'; antisense, 5'- 375 
AGACAGCCAGGAGAAATCAAACAG -3'), HPRT (sense, 5'- 376 
TGACCTTGATTTATTTTGCATACC -3'; antisense, 5'- CGCTTTCCATGTGTGAGGTGATG -3'), 377 
RPL13A (sense, 5'-CATAGGAAGCTGGGAGCAAG-3'; antisense, 5'-378 
GCCCTCCAATCAGTCTTCTG-3'). For EGFR, NOD1 and NOD2, validated primers from Bio-Rad 379 
were used (Unique Assay ID qHsaCID0007564, qHsaCED0005079 and qHsaCED0056944 380 
respectively). For quantitative real-time PCR, the iQTM SYBR Green Supermix (Bio-Rad 381 
Laboratories Inc., Segrate, MI, Italy) was used according to the manufacturer’s instructions. 382 
Reactions were run in duplicate on a CFX96 Real Time System and analyzed by BioRad CFX 383 
Maestro Software (Bio-Rad Laboratories Inc.). Gene expression was normalized to HPRT or 384 
RPL13A mRNA content. 385 
 MTT assay. MSC cell viability was measured by MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-386 
diphenyltetrazolium bromide assay (Sigma Aldrich, MO, USA). Cells were seeded at a density of 387 
2x103/well in 96-well plates. After 24 h of incubation in RPMI 10% FBS without antibiotics, cells 388 
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were infected with B. henselae (MOI 100). The medium was changed after 4 days to wash out all 389 
extracellular bacteria. When indicated, cells were treated with heat-killed B. henselae. Cells were then 390 
incubated for 3 h with 20 µl MTT (final concentration 0,5 mg/ml). Formazan crystals were solubilized 391 
for 10 min in 100 µl DMSO, and OD 570 nm was measured using a microplate reader (VICTOR3TM, 392 
PerkinElmer, MA, USA).  To determine the contribution of bacteria in MTT reduction to overall 393 
values of infected MSCs, a bacterial suspension with the same concentrations per milliliter of those 394 
recovered from cells was assessed in parallel and the obtained values subtracted to results from 395 
infected cells. Annexin V Assay. MSCs untreated or infected for 96 h with B. henselae were stained 396 
with annexin V-FITC and PI (Sigma Aldrich) according to the manufacturer’s instructions. Samples 397 
were analyzed by FACS Calibur (Becton Dickinson), and results were quantified using FlowLogic 398 
(Miltenyi Biotec, Bergisch Gladbach, Germany). 399 
 Flow cytometry. MSCs were collected at the indicated times after infection and preincubated 400 
for 30 min at 4°C in 1X PBS supplemented with 2% goat serum and 0.2% sodium azide, washed 401 
twice with 1% bovine serum albumin (BSA). Successively, cells were incubated for 30 min at 4°C 402 
with anti-human TLR-2 FITC (mouse IgG2a) and anti-human TLR-4 PE (mouse IgG2a) or respective 403 
isotype controls (all from BioLegend CA, USA).  Flow cytometry analysis was performed using 404 
FACS Calibur and FlowLogic as described above. 405 
 Cytokine measurements.  MSCs seeded in 24-well plates were infected with a MOI of 100 406 
for the indicated times. For some experiments, cells werepretreated with the pharmacological 407 
inhibitors gefitinib and GSK583 or the neutralizing antibody anti-TLR2 ). The neutralizing antibody 408 
anti‐TLR2 (anti‐human TLR2‐IgA, clone B4H2) and the human IgA2 isotype control (both purchased 409 
from InvivoGen, CA, USA). Cell-free supernatants were then harvested to measure human VEGF-410 
A, CXCL8, IL-6 and CCL5 production by ELISA (R&D Systems, Minneapolis, MN, USA). To 411 
quantify human PDGF-D, a specific kit from Elabscience (Wuhan, Hubei, P.R.C) was employed. 412 
   413 
 Angiogenesis array. The human angiogenesis array (Proteome ProfilerTM Array; R&D 414 
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Systems) was used to assess the expression of 55 angiogenic-related proteins in MSCs uninfected or 415 
infected with B. henselae for 96 h. The array membranes were probed with pooled supernatants 416 
derived from three independent experiments according to manufacturer’s instructions.  417 
Chemiluminescent signal was acquired by ChemiDocTM Imaging System (BioRad). 418 
The signal intensity of each antigen-specific antibody spot was quantified using Fiji-ImageJ (NIH) 419 
software. For comparison of the relative expression of proteins in uninfected vs infected cells, the 420 
mean pixel density of the pair of duplicate spots for each protein, after subtraction of the mean pixel 421 
density of the negative control spots of the respective array, was normalized to the mean pixel density 422 
of the positive control spots. Heat map analysis using the normalized data was performed by 423 
GraphPad PRISM 8.0 software.  424 
 Sprouting assay. Sprouting of HUVEC spheroids was assessed as described previously (59). 425 
Briefly, spheroids were prepared in 20% methylcellulose medium, embedded in a fibrin gel and 426 
stimulated with recombinant human VEGF-A165 (30 ng/mL) (R&D System, MN, USA) or with 427 
different concentrations of CM from uninfected or infected MSCs. The number of radially growing 428 
cell sprouts was counted after 24 h using an Axiovert 200M microscope equipped with LD A Plan 429 
20X/0.30PH1 objective (Carl Zeiss) and expressed as relative increase over untreated spheroids. 430 
 Motility assay. HUVEC motility assay was based on “scratch” wounding of a confluent 431 
monolayer. Briefly, HUVECs (1 × 105) were seeded onto 0.1 % collagen type I (BD Biosciences, 432 
Italy)-coated six-well plates in complete medium until a confluent monolayer was formed. The cell 433 
monolayers were scratched using a pipette tip, washed with 1X PBS to remove the undetached cells 434 
and treated with MSC conditioned medium. After 24 h, cells were photographed under an Axiovert 435 
200M microscope (Carl Zeiss) equipped with LD A Plan 20X/0.30PH1. The healed area was 436 
quantified through computerized analysis by subtracting the wound area at 24 h from the initial area. 437 
 Tube formation assay. EC vessel formation was assessed by tube morphogenesis assay in a 438 
three-dimensional (3D) collagen matrix. To this end, HUVECs were seeded onto Reduced Growth 439 
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Factor Basement Membrane Matrix Cultrex® (BME) (Trevigen, Italy)-coated μ-slide angiogenesis 440 
chamber (Ibidi, Martinsried, Germany) at a density of 4.0x104 cells/cm2 in the absence or presence 441 
of CM from untreated or infected MSCs. After 48 h, cells were photographed using an Axiovert 200M 442 
microscope, and the number of meshes/field was counted. Statistical Analysis. Statistical 443 
significance was determined by non-parametric Student’s t-test and one-way analysis of variance 444 
followed by Tukey’s multiple-comparison test. Results were analyzed by GraphPad PRISM 8.0 445 
software (CA, USA). 446 
 447 
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FIGURE LEGENDS 652 
 653 
FIG. 1 B. henselae invades and persists in MSCs. (a) Invasion rates of B. henselae into MSCs were 654 
measured at day 1, 2, 3, 4 and 8 pi by gentamicin protection assay (GPA). After infection, cells were 655 
treated with gentamicin, and the number of intracellular bacteria was determined by CFU count. Data 656 
are expressed as mean ± SEM from two independent experiments carried out in triplicate (*P < 0.05 657 
vs Log10 CFU at 1 day; unpaired t-test). (b) Uninfected (CTRL) or B. henselae-infected MSCs (8 658 
days) were immunostained with an anti-BH antibody and counterstained with hematoxylin (upper 659 
panel 20X, lower panel 40X) or with goat anti-mouse Alexa Fluor® 594 conjugate and DAPI for 660 
immunofluorescence visualization (lower panel 100X). (c) To determine intracellular survival after 661 
4 days of infection, extracellular bacteria were killed by gentamicin treatment and incubated in normal 662 
medium for the indicated times. Mean values ± SEM of four independent experiments performed in 663 
triplicate (*P < 0.05; unpaired t-test). (d) Invasion rates of B. henselae in MSCs or HUVECs (60,000 664 
cells each, respectively). The number of intracellular bacteria as Log10 CFU was quantified at 1 day 665 
pi. Mean ± SEM of three experiments (*P < 0.05 MSCs vs HUVECs; unpaired t-test). 666 
FIG. 2 B. henselae localizes in invasome structures in MSCs. (a) Immunofluorescence of B. 667 
henselae-infected MSCs at 1, 2, 4 and 8 days pi and uninfected control MSCs (CTLR). B. henselae 668 
and cell membranes were stained with DAPI (cyan) and wheat germ agglutinin-Alexa Fluor 594 (red), 669 
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respectively, and analyzed with an epifluorescence microscope. Bacteria anchored to the MSC 670 
membrane are indicated with arrowheads. The thin arrows (2 and 4 days) indicate internalized 671 
bacteria within membrane bound compartments in the perinuclear area, whereas the large arrows (8 672 
days) highlight sizeable intracellular bacterial aggregates called invasomes. Each image also shows 673 
the basal portion of adherent MSC cells, with the orthogonal z reconstruction of the whole cell.  (b) 674 
Representative image of an invasome. MSCs were infected with B. henselae for 8 days and then 675 
washed and fixed with PFA. Samples were stained for F-actin (red), wheat germ agglutinin (WGA) 676 
(green) and DAPI and analyzed as described in panel a (bar: 10 µm).  677 
FIG. 3 B. henselae favors the proliferation of infected MSCs.  (a) MSC death was evaluated by 678 
FACS analysis after 4 days of infection with B. henselae. Uninfected MSCs (left panel; CTRL) and 679 
infected MSCs (right panel; B. henselae) were double-stained with FITC-annexin V and PI. 680 
Counterstaining with PI allowed differentiation of necrotic cells (upper left quadrant of the dot plot), 681 
late apoptotic cells (upper right quadrant) and early apoptotic cells (lower right quadrant). The 682 
percentages of cells localizing to these quadrants are indicated in each quadrant. Data are 683 
representative of three independent experiments. (b) The Bcl-2/Bax expression ratio was analyzed in 684 
control and B. henselae-infected MSCs at 2 days pi by qPCR. Gene expression was normalized to 685 
HPRT. Data are expressed as mean ± SEM of four independent experiments (ns not significant; 686 
unpaired t-test). (c) Proliferation assay. MSCs were treated as indicated for 0, 2, 4, and 8 days and 687 
analyzed by MTT assay. Untreated MSCs (white circle); B. henselae infected MSC (black circle); 688 
and heat killed B. henselae-treated MSCs (HK B.henselae) (grey circle). Data are expressed as mean 689 
± SEM of three independent experiments performed in triplicate(*P < 0.05 B. henselae vs CTRL, 690 
unpaired t-test). 691 
FIG. 4 Expression of TLR2, NOD1 and EGFR in B. henselae-infected MSCs.  (a) mRNA 692 
expression levels of TLR2, TLR4, NOD1 and EGFR in uninfected (white bar) and B. henselae-693 
infected MSCs (black bar) were determined by qPCR and normalized to RPL13A. Data are expressed 694 
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as mean ± SEM of four independent experiments (* P < 0.05; unpaired t-test). (b) TLR2 and TLR4 695 
protein expression levels on MSC membranes were analyzed by FACS in MSCs at 4 days pi. Cells 696 
were immunostained with anti-TLR2, anti-TLR4 or specific isotype control antibodies. The 697 
percentages of positive cells are indicated in each quadrant. Fluorescence minus one (FMO) controls 698 
for the antibodies are shown as well. Data are representative of three independent experiments (left 699 
panel) or as mean ± SEM (right panel). (c) Cell extracts from MSCs infected with B. henselae for 30, 700 
60, and 120 min or with hEGF (50 ng/mL) for 15 min were subjected to immunoblotting using anti-701 
EGFR pY1068 or anti-EGFR antibodies. (d) Analysis of CXCL8 in the supernatants from uninfected 702 
or B. henselae-infected MSCs pre-treated or not for 6 h with a neutralizing anti-TLR2 antibody (10 703 
μg/mL) (upper panel, n=6 experiments) or with the EGFR inhibitor gefitinib (10 μM) or the RIP2K 704 
inhibitor GSK583 (1 μM) (lower panel, n= 4 experiments) and then stimulated for 96 h. Data are 705 
shown as percentage (means ± SEM) of CXCL8 production compared to specific isotype control 706 
antibody or DMSO respectively set as 100% (* P < 0.05 vs B. henselae-infected cells; unpaired t-707 
test). (e)  To evaluate B. henselae internalization, MSCs were pretreated for 6 h with the neutralizing 708 
anti-EGFR (10 μg/mL) (upper panel, n=3 independent experiments) or gefitinib (10 μM) (lower 709 
panel, n=4 independent experiments), and CFU values of intracellular bacteria,  determined, after 1 710 
and 2 days of incubation, are expressed as percentage relative to CFU of specific isotype control 711 
antibody or DMSO-treated cellsset as 100%. Data are shown as mean ± SEM; * P < 0.05 vs 712 
internalized bacteria in untreated cells; unpaired t-test.  713 
FIG. 5 Conditioned medium from B. henselae-infected MSCs curbs the infection rates and 714 
angiogenic response of HUVECs. The effects of conditioned medium (CM) from B. henselae-715 
infected MSCs were tested by means of different angiogenic assays. (a) HUVEC monolayers were 716 
wounded with a 1.0-mm-wide rubber policeman and incubated in fresh medium supplemented with 717 
5% FCS and 1:2 diluted CM from infected (black bar, CM-MSC CTRL) or uninfected (white bar, 718 
CM-MSC B. henselae) MSCs. After 1 day, HUVECs invading the wound were quantified by  digital 719 
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imaging to calculate the relative increment in cell-covered area induced by MSC-CM compared to 720 
untreated HUVECs. Mean ± SEM of three independent experiments. *P < 0.05 vs Ctrl; unpaired t-721 
test. (b) Sprouting analysis of HUVEC spheroids. Spheroids were prepared in 20% methylcellulose 722 
medium, embedded in fibrin gel and stimulated with 1:2 diluted CM obtained from MSCs treated in 723 
the presence (black bar) or absence (white bar) of bacteria or with 30 ng/ml VEGF-A (dashed bar). 724 
The number of growing cell sprouts was counted after 1 day. Data are expressed as mean fold change 725 
vs Ctrl ± SEM of 20-40 spheroids/ experimental condition in three independent experiments and 726 
indicated as fold increase in the number of sprouts/spheroid vs Ctrl. *P < 0.05vs Ctrl; unpaired t-test. 727 
(c) The effect of CM from uninfected vs B. henselae-infected MSCs on HUVEC morphogenesis was 728 
assessed by tube morphogenesis assay in three-dimensional (3D) collagen matrix. HUVECs were 729 
seeded (40000 cells/cm2) on Cultrex Extracellular Matrix in the presence of 1:2 diluted CM from 730 
uninfected (white bar) or B. henselae-infected MSCs (black bar). After 8 h, the formation of capillary-731 
like structures was examined. Representative images are shown in the left panels. Quantification 732 
(right panel) was performed to calculate the relative increment in  capillary-like structure induced by 733 
MSC-CM compared to untreated HUVECs. Data are expressed as mean ± SEM relative to three 734 
independent experiments. * P < 0.05 vs Ctrl; unpaired t-test. (d)  Invasion rate of B. henselae in 735 
HUVECs (expressed as total CFUs) after 1 day of infection in the absence (grey bar) or presence of 736 
1:2 diluted CM-MSC CTRL (white bar) and CM-MSC B. henselae (black bar).  Mean ± SEM of three 737 
independent experiments * P < 0.05; unpaired t-test. 738 
FIG. 6 Angiogenic signature of B. henselae-infected MSCs. (a) Human angiogenesis antibody 739 
array analysis was performed using a pool of supernatants from 96 h uninfected MSC (CTRL) or B. 740 
henselae-infected MSCs. Some of the most representative angiogenic factors are highlighted in 741 
different colors. (b) Representative heat map (left panel) and relative gene expression shown as 742 
normalized pixel density of the duplicated spots for each angiogenic-related protein in the array of 743 
supernatants of MSCs and B. henselae-infected MSCs (right panel). * P < 0.01 ** P < 0.001 vs CTRL; 744 
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ANOVA followed by Tukey’s multiple-comparison test. (c) Quantification of VEGF-A, CXCL8, IL-745 
6, CCL5 and PDGF-D production in uninfected (CTRL) and B. henselae-infected MSCs. Data are 746 
expressed as mean ± SEM of three independent experiments. * P < 0.05 vs CTRL; unpaired t-test. 747 
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